On Apr. 2, 2020, Novartis announced plans to initiate a phase III clinical trial in collaboration with Incyte…
On Apr. 2, 2020, a University of Chicago team announced that it had mapped confirmed COVID-19 infections per…
On Apr. 2, 2020, an international team led by University of British Columbia (UBC) researcher Dr. Josef Penninger…
On Apr. 2, 2020, Vir Biotech and Alnylam Pharma announced an expansion to their broad multi-target existing collaboration…
On Apr. 2, 2020, Cerus announced that the University Hospital Basel transfused the first two COVID-19 patients with…
On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global…
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
On Apr. 2, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to the U.S….
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
On Apr. 2, 2020, George Washington University Hospital announed it had used Virtual Reality technology to see into…
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies…
On Apr. 2, 2020, a study in Neuron offers clues to why autism spectrum disorder (ASD) is more…
On Apr. 1, 2020, Philips announced that it can help general practitioners and healthcare institutions manage the increased…
On Apr. 1, 2020, Amgen announced it had consummated the purchase from Astellas of 49% of shares of…
On Apr. 1, 2020, ImmunityBio, a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it…
On Apr. 1, 2020, Innovation Pharma it had received data supporting Brilacidinﾒs direct inhibition of SARS-CoV-2, the novel…
On Apr. 1, 2020, Innovation Pharma announced BARDA had initiated funding to support the onshoring of Paratek manufacturing…
On Apr. 1, 2020, Cantel Medical announced it has accelerated surgical earloop mask production by its HuFriedyGroup dental…
On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S….
On Apr. 1, 2020, Diffusion Pharmaceuticals announced it had begun a cooperative research effort with University of Virginia…
On Apr. 1, 2020, new evidence in The American Journal of Tropical Medicine and Hygiene suggested that the…
On Apr. 1, 2020, a University of Washington Medicine led study of 24 of the most critically ill…
On Mar. 31, 2020, NIH researchers announced they had discovered a second gene that causes melorheostosis, a rare…